Skip to main content
Erschienen in: Heart and Vessels 4/2023

01.11.2022 | Original Article

Serum potassium in elderly heart failure patients as a predictor of readmission within 1 year

verfasst von: Gechu Shang, Yan Gao, Kewei Liu, Xiaoyong Wang

Erschienen in: Heart and Vessels | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Blood potassium levels are associated with adverse outcomes in patients with congestive heart failure (HF). However, it is unclear whether there are differences in outcome events in elderly patients with different blood potassium levels at the time of emergency readmission within 1 year. This study used data from patients hospitalized with HF, integrating electronic medical records from the PhysioNet restricted health data database and external outcome data. We conducted a retrospective study of HF patients aged 60 years and older, using baseline data, comorbidities, laboratory tests, and medication use as covariates to analyze the effect of serum potassium levels on outcome events, with the primary outcome being readmission within 1 year. A priori was used to calculate the sample size, and this retrospective cohort study included a total of 788 elderly HF patients, of whom 20.3% had hypokalaemia (K+  < 3.5 mmol/L) and 14.7% had hyperkalemia (K+  > 4.7 mmol/L). According to a multivariate Cox regression model, patients with hyperkalemia had a shorter time interval between readmissions within 1 year, with a hazard ratio (HR) and its 95% CI of 1.134 (1.006–1.279). Three models were used to analyze patients with different blood potassium levels and, after correction, the high potassium group was at high risk relative to the low and normal groups, with significant differences in outcome events, with HRs and their 95% CI of 1.266 (1.03–1.557), 1.245 (1.01–1.534), and 1.439 (1.142–1.812), respectively. The robustness of the model was also demonstrated by competing risk models with subgroup analysis, showing that blood potassium levels had a stable effect on outcome events and were not altered by covariates (age, sex, diabetes, chronic kidney disease, NT-proBNP, high-sensitivity troponin, and glomerular filtration rate). The results show that high blood potassium levels are associated with the outcome event of readmission within 1 year in elderly patients with HF. Blood potassium levels at the time of the first hospitalization may therefore be a valuable predictor.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Sabbatini AR, Kararigas G (2020) Menopause-related estrogen decrease and the pathogenesis of HFpEF: JACC review topic of the week. J Am Coll Cardiol 75:1074–1082CrossRefPubMed Sabbatini AR, Kararigas G (2020) Menopause-related estrogen decrease and the pathogenesis of HFpEF: JACC review topic of the week. J Am Coll Cardiol 75:1074–1082CrossRefPubMed
2.
Zurück zum Zitat Wong CW, Tafuro J, Azam Z, Satchithananda D, Duckett S, Barker D, Patwala A, Ahmed FZ, Mallen C, Kwok CS (2021) Misdiagnosis of heart failure: a systematic review of the literature. J Card Fail 27:925–933CrossRefPubMed Wong CW, Tafuro J, Azam Z, Satchithananda D, Duckett S, Barker D, Patwala A, Ahmed FZ, Mallen C, Kwok CS (2021) Misdiagnosis of heart failure: a systematic review of the literature. J Card Fail 27:925–933CrossRefPubMed
3.
Zurück zum Zitat Nair N, Gongora E (2020) Stem cell therapy in heart failure: where do we stand today? Biochim Biophys Acta Mol Basis Dis 1866:165489CrossRefPubMed Nair N, Gongora E (2020) Stem cell therapy in heart failure: where do we stand today? Biochim Biophys Acta Mol Basis Dis 1866:165489CrossRefPubMed
4.
Zurück zum Zitat Ide T, Kaku H, Matsushima S, Tohyama T, Enzan N, Funakoshi K, Sumita Y, Nakai M, Nishimura K, Miyamoto Y, Tsuchihashi-Makaya M, Hatano M, Komuro I, Tsutsui H, JROADHF Investigators (2021) Clinical characteristics and outcomes of hospitalized patients with heart failure from the large-scale Japanese registry of acute decompensated heart failure (JROADHF). Circ J 85:1438–1450CrossRefPubMed Ide T, Kaku H, Matsushima S, Tohyama T, Enzan N, Funakoshi K, Sumita Y, Nakai M, Nishimura K, Miyamoto Y, Tsuchihashi-Makaya M, Hatano M, Komuro I, Tsutsui H, JROADHF Investigators (2021) Clinical characteristics and outcomes of hospitalized patients with heart failure from the large-scale Japanese registry of acute decompensated heart failure (JROADHF). Circ J 85:1438–1450CrossRefPubMed
5.
Zurück zum Zitat Pagliaro BR, Cannata F, Stefanini GG, Bolognese L (2020) Myocardial ischemia and coronary disease in heart failure. Heart Fail Rev 25:53–65CrossRefPubMed Pagliaro BR, Cannata F, Stefanini GG, Bolognese L (2020) Myocardial ischemia and coronary disease in heart failure. Heart Fail Rev 25:53–65CrossRefPubMed
6.
Zurück zum Zitat Ferreira JP, Butler J, Rossignol P, Pitt B, Anker SD, Kosiborod M, Lund LH, Bakris GL, Weir MR, Zannad F (2020) Abnormalities of potassium in heart failure: JACC state-of-the-art review. J Am Coll Cardiol 75:2836–2850CrossRefPubMed Ferreira JP, Butler J, Rossignol P, Pitt B, Anker SD, Kosiborod M, Lund LH, Bakris GL, Weir MR, Zannad F (2020) Abnormalities of potassium in heart failure: JACC state-of-the-art review. J Am Coll Cardiol 75:2836–2850CrossRefPubMed
7.
Zurück zum Zitat Tomasoni D, Adamo M, Lombardi CM, Metra M (2019) Highlights in heart failure. ESC Heart Fail 6:1105–1127CrossRefPubMed Tomasoni D, Adamo M, Lombardi CM, Metra M (2019) Highlights in heart failure. ESC Heart Fail 6:1105–1127CrossRefPubMed
8.
Zurück zum Zitat Palmer BF, Carrero JJ, Clegg DJ, Colbert GB, Emmett M, Fishbane S, Hain DJ, Lerma E, Onuigbo M, Rastogi A, Roger SD, Spinowitz BS, Weir MR (2021) Clinical management of hyperkalemia. Mayo Clin Proc 96:744–762CrossRefPubMed Palmer BF, Carrero JJ, Clegg DJ, Colbert GB, Emmett M, Fishbane S, Hain DJ, Lerma E, Onuigbo M, Rastogi A, Roger SD, Spinowitz BS, Weir MR (2021) Clinical management of hyperkalemia. Mayo Clin Proc 96:744–762CrossRefPubMed
9.
Zurück zum Zitat Formiga F, Chivite D, Corbella X, Conde-Martel A, Arévalo-Lorido JC, Trullàs JC, Silvestre JP, García SC, Manzano L, Montero-Pérez-Barquero M, RICA investigators group (2019) Influence of potassium levels on 1 year outcomes in elderly patients with acute heart failure. Eur J Intern Med 60:24–30CrossRefPubMed Formiga F, Chivite D, Corbella X, Conde-Martel A, Arévalo-Lorido JC, Trullàs JC, Silvestre JP, García SC, Manzano L, Montero-Pérez-Barquero M, RICA investigators group (2019) Influence of potassium levels on 1 year outcomes in elderly patients with acute heart failure. Eur J Intern Med 60:24–30CrossRefPubMed
10.
Zurück zum Zitat Núñez J, Bayés-Genís A, Zannad F, Rossignol P, Núñez E, Bodí V, Miñana G, Santas E, Chorro FJ, Mollar A, Carratalá A, Navarro J, Górriz JL, Lupón J, Husser O, Metra M, Sanchis J (2018) Long-term potassium monitoring and dynamics in heart failure and risk of mortality. Circulation 137:1320–1330CrossRefPubMed Núñez J, Bayés-Genís A, Zannad F, Rossignol P, Núñez E, Bodí V, Miñana G, Santas E, Chorro FJ, Mollar A, Carratalá A, Navarro J, Górriz JL, Lupón J, Husser O, Metra M, Sanchis J (2018) Long-term potassium monitoring and dynamics in heart failure and risk of mortality. Circulation 137:1320–1330CrossRefPubMed
12.
Zurück zum Zitat Kitamura M, Izawa KP, Taniue H, Mimura Y, Ikeda Y, Nagashima H, Brubaker PH (2018) Activities of daily living at different levels of renal function in elderly hospitalized heart failure patients. Aging Clin Exp Res 30:45–51CrossRefPubMed Kitamura M, Izawa KP, Taniue H, Mimura Y, Ikeda Y, Nagashima H, Brubaker PH (2018) Activities of daily living at different levels of renal function in elderly hospitalized heart failure patients. Aging Clin Exp Res 30:45–51CrossRefPubMed
13.
Zurück zum Zitat Zhang Z, Cao L, Chen R, Zhao Y, Lv L, Xu Z, Xu P (2021) Electronic healthcare records and external outcome data for hospitalized patients with heart failure. Sci Data 8:46CrossRefPubMedPubMedCentral Zhang Z, Cao L, Chen R, Zhao Y, Lv L, Xu Z, Xu P (2021) Electronic healthcare records and external outcome data for hospitalized patients with heart failure. Sci Data 8:46CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Goldberger AL, Amaral LA, Glass L, Hausdorff JM, Ivanov PC, Mark RG, Mietus JE, Moody GB, Peng CK, Stanley HE (2000) Physio bank, physiotoolkit, and physionet: components of a new research resource for complex physiologic signals. Circulation 101:E215–E220CrossRefPubMed Goldberger AL, Amaral LA, Glass L, Hausdorff JM, Ivanov PC, Mark RG, Mietus JE, Moody GB, Peng CK, Stanley HE (2000) Physio bank, physiotoolkit, and physionet: components of a new research resource for complex physiologic signals. Circulation 101:E215–E220CrossRefPubMed
15.
Zurück zum Zitat Duflos C, Troude P, Strainchamps D, Ségouin C, Logeart D, Mercier G (2020) Hospitalization for acute heart failure: the in-hospital care pathway predicts 1 year readmission. Sci Rep 10:10644CrossRefPubMedPubMedCentral Duflos C, Troude P, Strainchamps D, Ségouin C, Logeart D, Mercier G (2020) Hospitalization for acute heart failure: the in-hospital care pathway predicts 1 year readmission. Sci Rep 10:10644CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Toledo CC, Vellosa Schwartzmann P, Miguel Silva L, da Silva FG, Bianchini Cardoso F, Citelli Ribeiro V, Paim LR, Antunes-Correa LM, Carvalho Sposito A, Matos Souza JR, Modolo R, Nadruz W, de FernandesCarvalho LS, Coelho-Filho OR (2021) Serum potassium levels provide prognostic information in symptomatic heart failure beyond traditional clinical variables. ESC Heart Fail 8:2133–2143CrossRefPubMedPubMedCentral Toledo CC, Vellosa Schwartzmann P, Miguel Silva L, da Silva FG, Bianchini Cardoso F, Citelli Ribeiro V, Paim LR, Antunes-Correa LM, Carvalho Sposito A, Matos Souza JR, Modolo R, Nadruz W, de FernandesCarvalho LS, Coelho-Filho OR (2021) Serum potassium levels provide prognostic information in symptomatic heart failure beyond traditional clinical variables. ESC Heart Fail 8:2133–2143CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Gao XP, Zheng CF, Liao MQ, He H, Liu YH, Jing CX, Zeng FF, Chen QS (2019) Admission serum sodium and potassium levels predict survival among critically ill patients with acute kidney injury: a cohort study. BMC Nephrol 20:311CrossRefPubMedPubMedCentral Gao XP, Zheng CF, Liao MQ, He H, Liu YH, Jing CX, Zeng FF, Chen QS (2019) Admission serum sodium and potassium levels predict survival among critically ill patients with acute kidney injury: a cohort study. BMC Nephrol 20:311CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Pugliese NR, De Biase N, Gargani L, Mazzola M, Conte L, Fabiani I, Natali A, Dini FL, Frumento P, Rosada J, Taddei S, Borlaug BA, Masi S (2021) Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing. Eur J Prev Cardiol 28:1650–1661CrossRefPubMed Pugliese NR, De Biase N, Gargani L, Mazzola M, Conte L, Fabiani I, Natali A, Dini FL, Frumento P, Rosada J, Taddei S, Borlaug BA, Masi S (2021) Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing. Eur J Prev Cardiol 28:1650–1661CrossRefPubMed
19.
Zurück zum Zitat Eriguchi M, Tsuruya K, Lopes M, Bieber B, McCullough K, Pecoits-Filho R, Robinson B, Pisoni R, Kanda E, Iseki K, Hirakata H (2022) Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients. ESC Heart Fail 9:1138–1151CrossRefPubMedPubMedCentral Eriguchi M, Tsuruya K, Lopes M, Bieber B, McCullough K, Pecoits-Filho R, Robinson B, Pisoni R, Kanda E, Iseki K, Hirakata H (2022) Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients. ESC Heart Fail 9:1138–1151CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Vaduganathan M, Pareek M, Kristensen AMD, Biering-Sørensen T, Byrne C, Almarzooq Z, Olesen TB, Olsen MH, Bhatt DL (2021) Prevention of heart failure events with intensive versus standard blood pressure lowering across the spectrum of kidney function and albuminuria: a SPRINT substudy. Eur J Heart Fail 23:384–392CrossRefPubMed Vaduganathan M, Pareek M, Kristensen AMD, Biering-Sørensen T, Byrne C, Almarzooq Z, Olesen TB, Olsen MH, Bhatt DL (2021) Prevention of heart failure events with intensive versus standard blood pressure lowering across the spectrum of kidney function and albuminuria: a SPRINT substudy. Eur J Heart Fail 23:384–392CrossRefPubMed
21.
Zurück zum Zitat Morales E, Cravedi P, Manrique J (2021) Management of chronic hyperkalemia in patients with chronic kidney disease: an old problem with news options. Front Med (Lausanne) 8:653634CrossRefPubMed Morales E, Cravedi P, Manrique J (2021) Management of chronic hyperkalemia in patients with chronic kidney disease: an old problem with news options. Front Med (Lausanne) 8:653634CrossRefPubMed
22.
Zurück zum Zitat Villa-Zapata L, Carhart BS, Horn JR, Hansten PD, Subbian V, Gephart S, Tan M, Romero A, Malone DC (2021) Serum potassium changes due to concomitant ACEI/ARB and spironolactone therapy: a systematic review and meta-analysis. Am J Health Syst Pharm 78:2245–2255CrossRefPubMed Villa-Zapata L, Carhart BS, Horn JR, Hansten PD, Subbian V, Gephart S, Tan M, Romero A, Malone DC (2021) Serum potassium changes due to concomitant ACEI/ARB and spironolactone therapy: a systematic review and meta-analysis. Am J Health Syst Pharm 78:2245–2255CrossRefPubMed
24.
Zurück zum Zitat Sfairopoulos D, Arseniou A, Korantzopoulos P (2021) Serum potassium and heart failure: association, causation, and clinical implications. Heart Fail Rev 26:479–486CrossRefPubMed Sfairopoulos D, Arseniou A, Korantzopoulos P (2021) Serum potassium and heart failure: association, causation, and clinical implications. Heart Fail Rev 26:479–486CrossRefPubMed
25.
Zurück zum Zitat Liu S, Zhao D, Wang M, Qi Y, Sun J, Liu J, Li Y, Liu J (2021) Association of serum potassium levels with mortality and cardiovascular events: findings from the Chinese multi-provincial cohort study. J Gen Intern Med 37(10):2446–2453CrossRefPubMed Liu S, Zhao D, Wang M, Qi Y, Sun J, Liu J, Li Y, Liu J (2021) Association of serum potassium levels with mortality and cardiovascular events: findings from the Chinese multi-provincial cohort study. J Gen Intern Med 37(10):2446–2453CrossRefPubMed
26.
Zurück zum Zitat Brunelli SM, Spiegel DM, Du Mond C, Oestreicher N, Winkelmayer WC, Kovesdy CP (2018) Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients. Nephrol Dial Transplant 33(7):1207–1214CrossRefPubMed Brunelli SM, Spiegel DM, Du Mond C, Oestreicher N, Winkelmayer WC, Kovesdy CP (2018) Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients. Nephrol Dial Transplant 33(7):1207–1214CrossRefPubMed
27.
Zurück zum Zitat Hagengaard L, Søgaard P, Espersen M, Sessa M, Lund PE, Krogager ML, Torp-Pedersen C, Kragholm KH, Polcwiartek C (2020) Association between serum potassium levels and short-term mortality in patients with atrial fibrillation or flutter co-treated with diuretics and rate- or rhythm-controlling drugs. Eur Heart J Cardiovasc Pharmacother 6:137–144CrossRefPubMed Hagengaard L, Søgaard P, Espersen M, Sessa M, Lund PE, Krogager ML, Torp-Pedersen C, Kragholm KH, Polcwiartek C (2020) Association between serum potassium levels and short-term mortality in patients with atrial fibrillation or flutter co-treated with diuretics and rate- or rhythm-controlling drugs. Eur Heart J Cardiovasc Pharmacother 6:137–144CrossRefPubMed
28.
Zurück zum Zitat Falk RS, Robsahm TE, Paulsen JE, Stocks T, Drake I, Heir T (2021) Fasting serum potassium and long-term mortality in healthy men. BMC Public Health 21:711CrossRefPubMedPubMedCentral Falk RS, Robsahm TE, Paulsen JE, Stocks T, Drake I, Heir T (2021) Fasting serum potassium and long-term mortality in healthy men. BMC Public Health 21:711CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Li Z, Zhao H, Wang J (2021) Metabolism and chronic inflammation: the links between chronic heart failure and comorbidities. Front Cardiovasc Med 8:650278CrossRefPubMedPubMedCentral Li Z, Zhao H, Wang J (2021) Metabolism and chronic inflammation: the links between chronic heart failure and comorbidities. Front Cardiovasc Med 8:650278CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Gargiulo P, Marsico F, Renga F, Dell’Aversana S, Esposito I, Marciano C, Dellegrottaglie S, Perrone-Filardi P, Paolillo S (2020) The metabolic syndrome in heart failure: insights to specific mechanisms. Heart Fail Rev 25:1–7CrossRefPubMed Gargiulo P, Marsico F, Renga F, Dell’Aversana S, Esposito I, Marciano C, Dellegrottaglie S, Perrone-Filardi P, Paolillo S (2020) The metabolic syndrome in heart failure: insights to specific mechanisms. Heart Fail Rev 25:1–7CrossRefPubMed
31.
Zurück zum Zitat Neuen BL, Oshima M, Perkovic V, Agarwal R, Arnott C, Bakris G, Cannon CP, Charytan DM, Edwards R, Górriz JL, Jardine MJ, Levin A, Neal B, De Nicola L, Pollock C, Rosenthal N, Wheeler DC, Mahaffey KW, Heerspink HJL (2021) Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial. Eur Heart J 42(48):4891–4901CrossRefPubMed Neuen BL, Oshima M, Perkovic V, Agarwal R, Arnott C, Bakris G, Cannon CP, Charytan DM, Edwards R, Górriz JL, Jardine MJ, Levin A, Neal B, De Nicola L, Pollock C, Rosenthal N, Wheeler DC, Mahaffey KW, Heerspink HJL (2021) Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial. Eur Heart J 42(48):4891–4901CrossRefPubMed
Metadaten
Titel
Serum potassium in elderly heart failure patients as a predictor of readmission within 1 year
verfasst von
Gechu Shang
Yan Gao
Kewei Liu
Xiaoyong Wang
Publikationsdatum
01.11.2022
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 4/2023
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-022-02192-y

Weitere Artikel der Ausgabe 4/2023

Heart and Vessels 4/2023 Zur Ausgabe

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.